Orchestra BioMed Holdings Inc - OBIO - stock price prediction, stock price target, analyst ratings from 7 analysts

Orchestra BioMed Holdings Inc has a share price target of US$ 14, revenue growth forecast of 16.7%, and profit growth estimate of -29.7% for FY25, based on top 7 analyst calls.